XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 28.59

+5.4%

10:57 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bluegreen who wrote (7475)	10/12/1998 4:14:00 PM
From: aknahow	Read Replies (1) of 17367

Psoriasis article. See last paragraph. pslgroup.com "Perhaps the most exciting of the new drugs to combat psoriasis are the fusion proteins, usually a combination of unique molecules with antibody fragments, he said. "These are proteins that block the activation of T-cells that lead to the development of psoriasis. Although not yet approved by the FDA, they have performed well in clinical trials. Just a few injections can result in dramatic improvement and may be the long-term answer to controlling the disease," Dr. Lebwohl said." Wonder who is involved in these clinical trials?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next